AT128587B - Radiological procedure. - Google Patents

Radiological procedure.

Info

Publication number
AT128587B
AT128587B AT128587DA AT128587B AT 128587 B AT128587 B AT 128587B AT 128587D A AT128587D A AT 128587DA AT 128587 B AT128587 B AT 128587B
Authority
AT
Austria
Prior art keywords
radiological procedure
sodium
urinary tract
iodomethanesulfonic
solutions
Prior art date
Application number
Other languages
German (de)
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Application granted granted Critical
Publication of AT128587B publication Critical patent/AT128587B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

  

   <Desc/Clms Page number 1> 
 
 EMI1.1 
 



   Es wurde gefunden, dass man Hohlsysteme des Körpers, wie z. B. Blutgefässe, Gelenkhöhlen, Fisteln, die Harnwege u. dgl.,   röntgenologisch   zur Darstellung bringen kann, indem man diese Hohlsysteme mit Lösungen von jodmethansulfosauren Salzen auffüllt. Zur Sichtbarmachung der Harnwege kann man auch so verfahren, dass man das jodmethansulfosaure Salz bzw. seine Lösungen dem Organismus auf einem der dafür üblichen Wege zuführt und die Zeit, während der das jodmethansulfosaure Salz mit dem Harn ausgeschieden wird, zur Röntgenaufnahme ausnutzt. Bei den in üblicher Weise durchgeführten röntgenographischen Aufnahmen erhält man ein naturgetreues Bild der betreffenden aufgefüllten Hohlorgane. Das beschriebene Verfahren stellt daher eine bemerkenswerte Bereicherung der Röntgentechnik dar. 



   Beispiel   l :   Einem durch entsprechende Diät vorbereiteten Menschen werden 20 g jodmethansulfosaures Natrium, in 100   em3 Wasser gelöst,   innerhalb 1-2 Minuten intravenös injiziert. Wenige 
 EMI1.2 
 der Harnwege liefert. 



   Man kann die Aufnahme auch mehrere Stunden nach der Injektion noch durchführen. 



   Beispiel 2 : Ein 5 kg schwerer Hund erhält 10    < /jodmethansulfosaures   Natrium, in Wasser gelöst, per os. Ein nach 30 Minuten angefertigtes Röntgenbild der Harnwege bringt dieses zur Darstellung. 



   Beispiel 3 : Bei einem Menschen werden mittels Ureter-Katheterismus die Nierenbecken mit 15% iger wässeriger Lösung von jodmethansulfosaurem Natrium in an sich bekannter Weise aufgefüllt. 



  Auf der wenig später hergestellten Röntgenaufnahme sind das Nierenbecken und die Ureteren in allen Einzelheiten sichtbar. 



   Ausser den vorzugsweise angewandten Natriumsalzen der Jodmethansulfosäure haben sich auch andere Salze dieser Säure mit anorganischen oder organischen Basen als brauchbar erwiesen. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 
 EMI1.1
 



   It has been found that hollow systems of the body, such as. B. blood vessels, joint cavities, fistulas, the urinary tract and the like. Like., can be made radiologically by filling these hollow systems with solutions of iodomethanesulfonic acid salts. To make the urinary tract visible, one can also proceed in such a way that the iodomethanesulfonic acid salt or its solutions are supplied to the organism in one of the usual ways and the time during which the iodomethanesulfonic acid salt is excreted in the urine is used for X-rays. In the case of the conventional radiographic recordings, a lifelike image of the filled hollow organs in question is obtained. The method described is therefore a remarkable addition to X-ray technology.



   Example 1: A person who has been prepared by an appropriate diet is injected intravenously within 1-2 minutes with 20 g of sodium iodomethane sulfate dissolved in 100 cubic meters of water. Few
 EMI1.2
 the urinary tract supplies.



   You can still record several hours after the injection.



   Example 2: A dog weighing 5 kg receives 10% sodium iodomethanesulfate, dissolved in water, orally. An X-ray of the urinary tract made after 30 minutes shows this.



   Example 3: In a person, the renal pelvis is filled with a 15% aqueous solution of sodium iodomethanesulfate in a manner known per se by means of ureteral catheterism.



  The renal pelvis and ureters are visible in every detail on the x-ray taken a little later.



   In addition to the sodium salts of iodomethanesulfonic acid which are preferably used, other salts of this acid with inorganic or organic bases have also proven to be useful.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

Claims (1)

PATENT-ANSPRUCH : Röntgenologisches Verfahren, dadurch gekennzeichnet, dass man jodmethansulfosaure Salze bzw. deren Lösungen zum röntgenographischen Sichtbarmachen von Hohlsystemen des Körpers verwendet. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: X-ray method, characterized in that iodomethanesulfonic acid salts or their solutions are used for the radiographic visualization of hollow systems of the body. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT128587D 1930-06-10 1931-06-09 Radiological procedure. AT128587B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE647244T 1930-06-10

Publications (1)

Publication Number Publication Date
AT128587B true AT128587B (en) 1932-06-10

Family

ID=6580954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT128587D AT128587B (en) 1930-06-10 1931-06-09 Radiological procedure.

Country Status (5)

Country Link
AT (1) AT128587B (en)
CH (1) CH161431A (en)
DE (1) DE647244C (en)
DK (1) DK48099C (en)
NL (1) NL31804C (en)

Also Published As

Publication number Publication date
NL31804C (en) 1934-01-15
DK48099C (en) 1933-12-04
CH161431A (en) 1933-04-30
DE647244C (en) 1937-06-30

Similar Documents

Publication Publication Date Title
AT128587B (en) Radiological procedure.
AT134007B (en) Radiological procedure.
AT136142B (en) Radiological procedure.
AT129942B (en) Contrast media for fluoroscopy.
DE735441C (en) X-ray contrast media
AT156940B (en) Radiological procedure.
AT148307B (en) X-ray contrast media.
CH165420A (en) Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-2-pyridone-N-acetic acid.
AT148785B (en) Process for the preparation of stable solutions of substances with anesthetic effect.
AT64787B (en) Method of making a cancer cure.
AT98253B (en) Process for obtaining durable vaccines from bacteria.
AT137681B (en) Process for increasing the water solubility of halogenoxy- or -oxopyridincarboxylic or -sulfonic acids.
CH168363A (en) Radiographic contrast agent.
CH163442A (en) Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-2-pyridone-N-acetic acid.
CH239111A (en) Process for the production of a contrast substance suitable for the radiographic representation of the organs of the animal and human body.
AT85026B (en) Method of making condoms.
AT166477B (en) Process for insolubilizing fibers of milk or soybean casein with chromium salts
AT133283B (en) Process for the preparation of durable, supersaturated calcium gluconate solutions.
AT60095B (en) Process for the production of colored bodies containing selenium or tellurium for healing purposes.
DE442853C (en) Process for the preparation of a preparation which is insoluble in body fluids and emits ª ‰ rays
CH163443A (en) Process for the production of a highly concentrated aqueous solution of a salt of 3,5-dibromo-4-pyridone-N-acetic acid.
AT129490B (en) Process for obtaining the anterior pituitary lobe hormone, which is characterized by its development-promoting and stimulating effect on the gonads, in a pure state.
AT129598B (en) Process for the production of solutions of basic quinine which can be used in therapy.
CH163441A (en) Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-4-pyridone-N-acetic acid.
AT151757B (en) Process for the preparation of stable aqueous solutions of all salts present in the blood.